<DOC>
	<DOCNO>NCT01105013</DOCNO>
	<brief_summary>This study clinical , multicenter , Phase III trial , evaluate efficacy safety tolnaftate cream treatment patient fungal infection Tinea foot , Tinea Tinea crural body .</brief_summary>
	<brief_title>Evaluate Efficacy Safety Tolnaftate Cream Treatment Patients With Fungal Infections</brief_title>
	<detailed_description>Study Clinical , multicenter , Phase III , evaluate efficacy safety 10mg/g tolnaftate cream treatment patient fungal infection Tinea foot , Tinea Tinea crural body .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Pedis</mesh_term>
	<mesh_term>Tolnaftate</mesh_term>
	<criteria>Patients sex , race , age 12 year ; Ability understand sign IC ( patient old age ) case minor monitor consent guardian ; Clinical diagnosis fungal infection tinea pedis ( ringworm foot ) tinea cruris ( ringworm groin region ) , tinea corporis ( ringworm body area ) ; Direct mycological exam positive fungi ; Pregnant woman nurse mother ; Use topical oral antifungal ; Use steroid ; Allergy hypersensitivity component product ; Clinical case tinea infection bacteria / eczema , tinea extensive onychomycosis .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>fungal infection</keyword>
	<keyword>tinea</keyword>
	<keyword>tonaftato</keyword>
</DOC>